133 related articles for article (PubMed ID: 38043438)
21. Real-world cost-effectiveness of stool-based colorectal cancer screening in a Medicare population.
Fisher DA; Karlitz JJ; Jeyakumar S; Smith N; Limburg P; Lieberman D; Fendrick AM
J Med Econ; 2021; 24(1):654-664. PubMed ID: 33902366
[TBL] [Abstract][Full Text] [Related]
22. Attitudes and Experiential Factors Associated with Completion of mt-sDNA Test Kit for Colorectal Cancer Screening.
Finney Rutten LJ; Zhu X; Treiman K; Madson G; Southwell B; Helmueller L; Alam S; Gates C; Squiers L
J Patient Exp; 2023; 10():23743735231213765. PubMed ID: 38026067
[TBL] [Abstract][Full Text] [Related]
23. Multitarget Stool DNA Screening in Clinical Practice: High Positive Predictive Value for Colorectal Neoplasia Regardless of Exposure to Previous Colonoscopy.
Eckmann JD; Ebner DW; Bering J; Kahn A; Rodriguez E; Devens ME; Lowrie KL; Doering K; Then S; Burger KN; Mahoney DW; Prichard DO; Wallace MB; Gurudu SR; Finney LJ; Limburg P; Berger B; Ahlquist DA; Kisiel JB
Am J Gastroenterol; 2020 Apr; 115(4):608-615. PubMed ID: 32068535
[TBL] [Abstract][Full Text] [Related]
24. A novel multitarget stool DNA test for colorectal cancer screening.
Malik P
Postgrad Med; 2016; 128(2):268-72. PubMed ID: 26753807
[TBL] [Abstract][Full Text] [Related]
25. Colorectal Neoplasia Detection in Individuals With Positive Multitarget Stool DNA Tests: Data From the New Hampshire Colonoscopy Registry.
Anderson JC; Robinson CM; Hisey WM; Edwards DK; Kneedler BL; Berger BM; Butterly LF
J Clin Gastroenterol; 2022 May-Jun 01; 56(5):419-425. PubMed ID: 33973962
[TBL] [Abstract][Full Text] [Related]
26. Impact of Patient Adherence to Stool-Based Colorectal Cancer Screening and Colonoscopy Following a Positive Test on Clinical Outcomes.
Fendrick AM; Fisher DA; Saoud L; Ozbay AB; Karlitz JJ; Limburg PJ
Cancer Prev Res (Phila); 2021 Sep; 14(9):845-850. PubMed ID: 34021023
[TBL] [Abstract][Full Text] [Related]
27. Diagnostic Performance of Multitarget Stool DNA and CT Colonography for Noninvasive Colorectal Cancer Screening.
Pickhardt PJ; Graffy PM; Weigman B; Deiss-Yehiely N; Hassan C; Weiss JM
Radiology; 2020 Oct; 297(1):120-129. PubMed ID: 32779997
[TBL] [Abstract][Full Text] [Related]
28. Lowering the colorectal cancer screening age improves predicted outcomes in a microsimulation model.
Fisher DA; Saoud L; Finney Rutten LJ; Ozbay AB; Brooks D; Limburg PJ
Curr Med Res Opin; 2021 Jun; 37(6):1005-1010. PubMed ID: 33769894
[TBL] [Abstract][Full Text] [Related]
29. Evaluating Outreach Methods for Multi-Target Stool DNA Test for Colorectal Cancer Screening Among an Employer Population.
Shepherd ME; Lecorps A; Harris-Shapiro J; Miller-Wilson LA
J Prim Care Community Health; 2021; 12():21501327211037892. PubMed ID: 34382887
[TBL] [Abstract][Full Text] [Related]
30. Colorectal cancer screening among African American church members: a qualitative and quantitative study of patient-provider communication.
Katz ML; James AS; Pignone MP; Hudson MA; Jackson E; Oates V; Campbell MK
BMC Public Health; 2004 Dec; 4():62. PubMed ID: 15601463
[TBL] [Abstract][Full Text] [Related]
31. The cost-effectiveness of non-invasive stool-based colorectal cancer screening offerings from age 45 for a commercial and medicare population.
Ebner D; Kisiel J; Barnieh L; Sharma R; Smith NJ; Estes C; Vahdat V; Ozbay AB; Limburg P; Fendrick AM
J Med Econ; 2023; 26(1):1219-1226. PubMed ID: 37752872
[TBL] [Abstract][Full Text] [Related]
32. Cross-sectional adherence with the multi-target stool DNA test for colorectal cancer screening in a medicaid population.
Miller-Wilson LA; Finney Rutten LJ; Van Thomme J; Burak Ozbay A; Laffin J; Limburg P
Prev Med Rep; 2022 Dec; 30():102032. PubMed ID: 36531112
[TBL] [Abstract][Full Text] [Related]
33. Multi-Target Stool DNA Test: Is the Future Here?
Sweetser S; Ahlquist DA
Curr Gastroenterol Rep; 2016 Jun; 18(6):30. PubMed ID: 27165404
[TBL] [Abstract][Full Text] [Related]
34. Colorectal cancer outcomes after screening with the multi-target stool DNA assay: protocol for a large-scale, prospective cohort study (the Voyage study).
Olson JE; Kirsch EJ; Edwards V DK; Kirt CR; Kneedler B; Laffin JJ; Weaver AL; St Sauver JL; Yost KJ; Finney Rutten LJ
BMJ Open Gastroenterol; 2020; 7(1):e000353. PubMed ID: 32128228
[TBL] [Abstract][Full Text] [Related]
35. Cost-Effectiveness of Multitarget Stool DNA Testing vs Colonoscopy or Fecal Immunochemical Testing for Colorectal Cancer Screening in Alaska Native People.
Redwood DG; Dinh TA; Kisiel JB; Borah BJ; Moriarty JP; Provost EM; Sacco FD; Tiesinga JJ; Ahlquist DA
Mayo Clin Proc; 2021 May; 96(5):1203-1217. PubMed ID: 33840520
[TBL] [Abstract][Full Text] [Related]
36. Multitarget Stool DNA Test Performance in an Average-Risk Colorectal Cancer Screening Population.
Bosch LJW; Melotte V; Mongera S; Daenen KLJ; Coupé VMH; van Turenhout ST; Stoop EM; de Wijkerslooth TR; Mulder CJJ; Rausch C; Kuipers EJ; Dekker E; Domanico MJ; Lidgard GP; Berger BM; van Engeland M; Carvalho B; Meijer GA
Am J Gastroenterol; 2019 Dec; 114(12):1909-1918. PubMed ID: 31764091
[TBL] [Abstract][Full Text] [Related]
37. Recent trends in colorectal cancer screening methods based on Medicare claims data.
Limburg PJ; Finney Rutten LJ; Ozbay AB; Kisiel J; Parton M
Curr Med Res Opin; 2021 Apr; 37(4):605-607. PubMed ID: 33476244
[TBL] [Abstract][Full Text] [Related]
38. Barriers to Follow-Up Colonoscopy After Positive FIT or Multitarget Stool DNA Testing.
Cooper GS; Grimes A; Werner J; Cao S; Fu P; Stange KC
J Am Board Fam Med; 2021; 34(1):61-69. PubMed ID: 33452083
[TBL] [Abstract][Full Text] [Related]
39. Projecting total costs and health consequences of increasing mt-sDNA utilization for colorectal cancer screening from the payer and integrated delivery network perspectives.
Hathway JM; Miller-Wilson LA; Jensen IS; Ozbay B; Regan C; Jena AB; Weinstein MC; Parks PD
J Med Econ; 2020 Jun; 23(6):581-592. PubMed ID: 32063100
[No Abstract] [Full Text] [Related]
40. Colorectal cancer screening preferences among physicians and individuals at average risk: A discrete choice experiment.
Heidenreich S; Finney Rutten LJ; Miller-Wilson LA; Jimenez-Moreno C; Chua GN; Fisher DA
Cancer Med; 2022 Aug; 11(16):3156-3167. PubMed ID: 35315224
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
